Population pharmacokinetics study with Amaryl® (Glimepiride) in pediatric and adult population with type 2 diabetes

Update Il y a 4 ans
Reference: EUCTR2014-004643-12

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To investigate the pharmacokinetics of Amaryl® in pediatric patients (8 to 16 years of age) with type 2 diabetes in comparison with adults patients (17 years or older of age) with type 2 diabetes under steady state


Inclusion criteria

  • Patients with Type 2 diabetes

Links